baber/WOPTO huggingface dataset:
Patent NZ-539824-A (NZ)
Title: X-ray backscatter mobile inspection van
Inventor: ADAMS WILLIAM
IPC: G01N23/20
Filed: 2003-11-03
Abstract: An inspection system for inspecting an object is disclosed. The system comprising: (a) a fully enclosed conveyance characterized by an enclosing body; (b) a source of penetrating radiation contained entirely within the body of the enclosed conveyance for generating penetrating radiation; (c) a spatial modulator for forming the penetrating radiation into a beam for irradiating the object with a time-variable scanning profile, where the object is disposed entirely outside the enclosing body; (d) a detector module contained, during the course of operation, entirely within the body of the fully enclosed conveyance for generating a scatter signal based on penetrating radiation scattered by contents of the object; (e) a proximity sensor for generating a relative motion signal based on a relative disposition of the enclosed conveyance and the inspected object; and (f) a controller for ascertaining a specified characteristic of the contents of the object. Addition to 539824
Patent NZ-541827-A (NZ)
Title: Safety shield for medical needles
Inventor: FERGUSON F MARK
Filed: 2004-04-05
Abstract: A medical needle shield apparatus (300) is provided that includes a needle hub (332) having an outer needle cannula (317) extending therefrom. An inner needle (316) is disposed for slidable movement with the outer needle cannula (317). At least one shield (300) is extensible from a retracted position to an extended position to enclose a distal end of the inner needle (317). The shield (300) includes a binding member (364) disposed within the shield (300) and defines binding surfaces (368) that form an aperture (366) configured for slidable receipt of the inner needle (316). The binding member (364) includes at least one drag inducing member (362) that engages the inner needle (316) during slidable receipt to create a drag force. The drag force facilitates rotation of the binding member (364) such that the binding surfaces (368) engage the inner needle (316) to prevent slidable movement. The binding member (364) further includes a needle communicating surface (372) extending therefrom that engages the inner needle (316) to prevent rotation of the binding member (364).
Patent NZ-542508-A (NZ)
Title: Nail gun safety interlock for stud and plate framing nailer table
Inventor: YOUNG GRAEME LAWRENCE
IPC: G05G1/52
Filed: 2005-09-20
Abstract: An apparatus for the fabrication of a frame intended to be used in the construction of a building is disclosed. The apparatus includes at least one controlled nail gun (15) adapted to fire nails substantially into a selected plane of the frame, feed nails from a belt of nails. The nail gun has a degree of movement in a plane perpendicular to the selected plane of the frame, with the position selected by a controlled set of actuators (17,18). A sensor mounted on the nail gun (15), whose output is based upon the presence of the frame, enables or disables an interlock associated the controlled firing of nails from the nail gun. Controlled clamps (5) are also integrated into the apparatus to hold the frame during fabrication. The nail gun (15) and associated nail supply, sensor, interlock and clamp are mounted on a carriage that moves along a set of rails. This accommodates the fabrication of different size frames. The frame is supported during fabrication by two support rails. The initiation of a nailing sequence is by way of an activation bar (19), whose use signals the controller to progress through the correct order of actions to nail the frame.
Patent NZ-542587-A (NZ)
Title: Complex comprising a TGF-beta binding protein and a BMP antagonist protein in specific association used to modulate bone mineralization
Inventor: WINKLER DAVID G
IPC: C07K14/705
Filed: 2004-03-12
Abstract: Provided is an isolated complex comprising a TGF-beta binding protein and a BMP antagonist protein in specific association, wherein: (i) the TGF-beta binding protein comprises a sclerostin polypeptide that is capable of specifically binding a first TGF-beta superfamily member polypeptide that is selected from the group consisting of a BMP-5 polypeptide and a BMP-6 polypeptide, and (ii) the BMP antagonist protein is selected from the group consisting of a Chordin polypeptide and a Noggin polypeptide, said BMP antagonist protein being capable of specifically binding at least one second TGF-beta superfamily member polypeptide that is selected from the group consisting of a BMP-2 polypeptide, a BMP-4 polypeptide and a BMP-7 polypeptide, and wherein the complex is incapable of binding to the first TGF-beta superfamily member polypeptide. Further provided are similar complexes, wherein the first cognate ligand is BMP-2, BMP-4, BMP-5, BMP-6 or BMP-7. Further provided are methods of identifying agents modulating binding between a TGF-beta binding protein and a BMP antagonist protein using the said complexes.
Patent NZ-543178-A (NZ)
Title: Method and apparatus for enhancing air-interface information exchange during a dormant packet data session
Inventor: CHEN AN MEI
IPC: H04W52/02
Filed: 2004-04-30
Abstract: A method and apparatus for exchanging information with a dormant target communication device in a wireless communication system is disclosed. The method includes the steps of: (a) sending a page message to a dormant target communication device to locate the dormant target communication device by a wireless infrastructure, (b) receiving a page response from the dormant target communication device, (c) forwarding information to the dormant target communication device by use of the wireless infrastructure, wherein the information is piggybacked onto a message acknowledging the receipt of the page response, and (d) forwarding a release order to the dormant target communication device. The release order is operable to cancel a timer on the dormant target communication device and thereby allow the dormant target communication device to start forwarding information in a short data burst format to the wireless infrastructure.
Patent NZ-545710-A (NZ)
Title: Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
Inventor: GONZALES JESUS E
IPC: C07D209/80
Filed: 2004-08-09
Abstract: Compounds of formula I, wherein the substituents are as defined in the specification, are useful for inhibiting sodium and calcium channels, and for treating acute, chronic, neuropathic, or inflammatory pain, arthritis, migraine, cluster headaches, trigeminal neuralgia, herpetic neuralgia, general neuralgias, epilepsy or epileptic conditions, neurodegenerative disorders, psychiatric disorders, anxiety, depression, myotonia, arrhythmia, movement disorders, neuroendocrine disorders, ataxia, multiple sclerosis, irritable bowel syndrome, incontinence, visceral pain, osteoarthritis pain, postherpetic neuralgia, diabetic neuropathy, radicular pain, sciatica, back pain, head or neck pain, severe or intractable pain, nociceptive pain, breakthrough pain, postsurgical pain, and cancer pain. Novel compounds of formula I-A are also disclosed.
Patent NZ-546640-A (NZ)
Title: Broadcast data receiver with base unit and detachable mobile recording unit
Inventor: FARRIMOND ANDREW
IPC: H04N5/00
Filed: 2006-04-18
Abstract: A broadcast data receiver is disclosed. The broadcast data receiver includes a base unit, and a mobile unit which is detachably attached to the base unit. The base unit is capable of receiving broadcast data directly from a broadcaster and/or from a further broadcast data receiver communicating therewith. Data is transmitted between the base unit and the mobile unit when the mobile unit is attached to the base unit, and detection means is provided in the receiver to detect detachment of the mobile unit from the base unit. Upon detection of detachment or reattachment of the mobile unit from the base unit, indication means provided in the receiver provides an indication to a user of one or more events that may be missed following detachment, or that have been missed during detachment of the mobile unit from the base unit.
Patent NZ-546647-A (NZ)
Title: An improved skylight panel
Inventor: JANSEN JAMES MATTHEW
Filed: 2006-04-20
Abstract: A skylight panel for connecting between sheeting panels is disclosed. The skylight panel includes a central portion (10), and first and second edges. Each edge includes an upper portion (25) that extends away from the central portion, and a lower portion (27) that extends down and away from the central portion. The upper and lower portions define a channel that receives and engages an edge of the sheeting panels. The lower portion of the first edge, lower portion of the second edge, and the central portion are symmetrical with respect to the longitudinal axis of the opening into which the skylight panel engages.
Patent NZ-565661-A (NZ)
Title: Method and apparatus for creating a fingerprint for a wireless network
Inventor: GOGIC ALEKSANDAR
IPC: H04W48/18
Filed: 2006-08-10
Abstract: A method of communications is disclosed. The method includes creating and storing in memory information relating to the location of a first communications network based on one or more reference signals from a second communications network. The information includes a fingerprint of the first communications network, phase information and signal strength information for the one or more reference signals.
Patent NZ-566642-A (NZ)
Title: Extended release pharmaceutical composition of metformin and a process for producing it
Inventor: JATHAR SHRIPAD RHUSHIKESH
IPC: A61K9/46
Filed: 2006-08-22
Abstract: An extended release pharmaceutical composition, comprising; about 55 to about 70% w/w metformin or a pharmaceutically acceptable salt thereof; about 5 to about 15% w/w gas generating agent; a hydrophilic or hydrophobic polymer as release retardant; the release retardant polymer comprising hydroxylethylcellulose, polyvinylpyrrolidone in combination with poly(vinyl alcohol), hydroxypropylcellulose, hydroxymethylcellulose, hydroxypropylmethylcellulose, gelatin, polyacrylic acid, polyethyleneoxide, poly(meth)acrylate, glyceryl behenate, polypropylene oxide, polyethylene, polypropylene, polycarbonate, polystyrene, polysulfone, polyphenylene oxide, polytetramethylene ether, or a mixture thereof; a disintegrant; one more hydrophilic polymer to provide system stability; the system stability polymer comprising sodium carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, or a mixture thereof; a hydrophilic polymer or a gum as release modifier, the release modifier comprising sodium carboxymethylcellulose, guar gum, gum arabic, locust bean gum, xanthan gum, or a mixture thereof; and optionally, other pharmaceutical excipients; wherein the composition: comprises about 5 to about 50% w/w hydrophilic polymer, hydrophobic polymer, gum or a mixture thereof; when immersed in 0.1 N hydrochloric acid, starts to floats on the surface within 0.5 minute to 5 minutes and continues to float for a period between 6 hours and 10 25 hours; and is in the form of a tablet that exhibits the following dissolution profile when tested in a USP type II apparatus at 50 rpm in 900 ml of 0.1 N HCl at 37° C: 10-45% of the metformin or salt thereof is released after 2 hours; 30 40-65% of the metformin or salt thereof is released after 4 hours; 60-80% of the metformin or salt thereof is released after 6 hours; 75-95% of the metformin or salt thereof is released after 8 hours; not less than 95% of the metformin or salt thereof is released after 12 hours.
Patent NZ-567850-A (NZ)
Title: Shoe insole for woman's foot with cradle structure formed by lateral portions on either side of central base, and cushioning pad above base
Inventor: CHESKIN MELVYN P
IPC: A43B17/00
Filed: 2006-11-02
Abstract: An insole providing cushioning and control of foot motion. The insole includes a base. A lateral border and a medial border cooperate to align and support the foot. The lateral border and medial border are firmer than the base. Further details are disclosed.
Patent NZ-568805-A (NZ)
Title: pentaaza-cyclopenta[b]fluoren-9-one inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
Inventor: GUEDAT PHILIPPE
IPC: A61K31/4192
Filed: 2006-12-05
Abstract: Disclosed is a pentaaza-cyclopenta[b]fluoren-9-one of formula (I): wherein: Het1 and Ru are defined in the specification; T, U, V, W, X are the same or different and independently C or N; Rv, Rw are independently H or absent; R3, R4, R5, R6 are each identical or different and are independently chosen from the group consisting of H, OAlk, Alk, Hal, NRR', CN, OH, OCF3, Aryle, Heteroaryle; Rand R' are each identical or different and are independently chosen from the group consisting of H, Alk, wherein Alk is optionally substituted by Hal, NRR', CN, OH, CF3, Aryle, Heteroaryle; or their pharmaceutically acceptable salts, hydrates, or hydrated salts, or their optical isomers, racemates, diastereomers or enantiomers. Also disclosed is the use of said fluoren-9-one for treating and/or preventing cancer and metastasis, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, inflammatory disorders, cardiovascular diseases and/or viral infectivity and/or latency in particular for Herpes simplex virus-1, Epstein-Barr virus or SARS coronavirus, inflammatory disorders, neurodegenerative disorders, preferably nervous cell damage caused by stroke, liver damage and liver failure resulting from acute or chronic infectious, ischemic or chemical liver injury, renal damage and renal failure resulting from acute or chronic infectious, ischemic or chemical kidney injury, heart damage and heart failure resulting from acute or chronic infectious, ischemic or chemical cardiac injury, diabetes resulting from acute or chronic autoimmune, chemical, oxidative or metabolic injury to the insulin beta-cells of the pancreatic islets, cancer and metastasis, cardiovascular diseases, immunological disorders, bone and joint diseases, osteoporosis and arthritis, ageing disorders, late onset diabetes and cataract, viral infections and diseases, bacterial infections and diseases, fungal infections and diseases, protozoal parasitic infections and diseases, round worm parasitic infections and diseases.
Patent NZ-569506-A (NZ)
Title: A force multiplier lever for a manually-operated drum pump attached to the drum around the pump port
Inventor: HOSHINO TAKAO
IPC: F04B9/14
Filed: 2006-12-06
Abstract: A manual leaver arrangement (10) for a drum pump (1) is disclosed. The arrangement (10) allows a pump (1) usually too hard to pump by hand to be operated manually and be cheaply adapted to this use. The pump (1) is connected to the drum (D) through a threaded opening in the top of the drum (D). A support plate (11) is trapped between the pump (1) and the drum (D). The support plate (11) has an extension (12) which supports a lever (13) at a pivot point. The piston (5) of the pump (1) is connected to the lever (13) at a point (13c) between the pivot point and where the lever is grasped in use (13b).
Patent NZ-573405-A (NZ)
Title: A brake system component for mounting to a compressed air reservoir on a commercial vehicle
Inventor: LEGEZA THOMAS S
IPC: F16M13/00
Filed: 2007-06-05
Abstract: Disclosed is a brake system component for mounting to a compressed air reservoir on a commercial vehicle. The brake system component comprises an apparatus (18) and an electrical control unit (14) for controlling roll stability on the vehicle. The apparatus (18) comprises a first end portion and a second end portion. The first end portion is positioned proximate to the reservoir. The first end portion includes one or more contact points for engaging the reservoir along a curved surface. The second end portion is configured to be fixed relative the first end portion. The second end portion is adapted to engage the electronic control unit (14) to impede its movement relative to the reservoir.
Patent NZ-575068-A (NZ)
Title: Analysis device for determining the presence of an analyte comprising a test strip having a separable second reagent zone.
Inventor: WU XIN
IPC: G01N33/52
Filed: 2007-07-24
Abstract: A device (20) is disclosed for determining the presence of an analyte in a liquid sample. The device comprises a test strip (131) defining a flow path. The test strip (131) comprises a second reagent zone (201) positioned along the flow path, a first reagent zone (121) located downstream of the second reagent zone (201) and a test zone (132) located downstream of the first reagent zone (121). The second reagent zone (201) comprises a first binding moiety being mobilizable by the liquid sample, the first binding moiety being capable of binding with the analyte to form a first complex. The first reagent zone (121) comprises a second binding moiety being mobilizable by the liquid sample, the second binding moiety being capable of binding with the first complex to form a second complex and comprising a detectable label. The test zone (132) comprises a third binding moiety being immobilized in the test zone (132), the third binding moiety capable of binding with the first or second complex. The second reagent zone (201) is separable from the first reagent zone (121) and prior to placing the second reagent zone (201) in fluid communication with the test strip (131), the liquid sample has already been in contact with the second reagent zone (201) for a period of time sufficient to effect formation of the first complex.
Patent NZ-581280-A (NZ)
Title: Method of cementing casing string using baffle adapter with inner bore sealing against cementing plug
Inventor: SZARKA DAVID D
IPC: E21B33/16
Filed: 2004-11-10
Abstract: A method of cementing a casing string consists of injecting a cement composition into the string, deploying within the string at least one cementing plug having an outer body and a detachable inner mandrel attached to the outer body, and installing a baffle adapter in the casing string, wherein the baffle adapter has an inner bore configured to engage and seal against the at least one cementing plug. Various other alternative restrictions are disclosed. (62) Divided Out of 547126
Patent NZ-582836-A (NZ)
Title: Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
Inventor: SCHAFFLER ACHIM
IPC: A61K9/00
Filed: 2010-01-22
Abstract: Provided is the use of a glucocorticoid contained in a delayed-release dosage form in the manufacture of a medicament for the treatment of a patient for the prevention of structural damages to the joints in rheumatoid arthritis, wherein the medicament is to be administered once daily for at least about two weeks, and wherein the delayed-release dosage form is administered in the evening, and has an in vivo lag time of from about 2 h to about 6 h after administration.
Patent NZ-583931-A (NZ)
Title: Psma binding ligand-linker conjugates and methods for using
Inventor: LOW PHILIP STEWART
IPC: A61K39/395
Filed: 2008-08-15
Abstract: Disclosed is a conjugate having the formula B-L-D, wherein B is a prostate specific membrane antigen (PSMA) binding or targeting ligand, L is a linker, and D is a drug, wherein the linker is covalently bound to the drug and the linker is covalently bound to the ligand, and where the linker comprises a chain of at least seven atoms providing that the ligand is not an antibody or antigen-binding fragment of an antibody.
Patent NZ-586859-A (NZ)
Title: Drug delivery system for administration of poorly water soluble pharmaceutically active substances
Inventor: ALEKSOV JULIAN
IPC: A61K9/14
Filed: 2008-12-18
Abstract: Disclosed is a drug delivery system for administration of at least one pharmaceutically active substance having a solubility per se in water of less than about 100 ìg/ml, said substance being in particulate form with an effective average particle size of less than about 100 nm, wherein - the substance particles have an effective average particle size of less than about 50 nm; - the substance particles are essentially amorphous; - the substance particles are entrapped in nanoparticles formed of a sodium salt of the methyl ester of N-all-trans-retinoyl cysteic acid, sodium salt of methyl ester of N-13-cis-retinoyl cysteic acid, or a combination thereof; and - the weight-to-weight ratio of said sodium salt of methyl ester of N-all-trans-retinoyl cysteic acid, sodium salt of methyl ester of N-13-cis-retinoyl cysteic acid, or a combination thereof, to said substance is in the range from about 0.5:1 to about 20:1. Also disclosed is a pharmaceutical composition comprising the drug deliver system and the method for preparing the drug delivery system or the composition comprising the delivery system and the use of the composition or delivery system in the manufacture of a medicament for treating cancer. Further disclosed is the use of a sodium salt of the methyl ester of N-all-trans-retinoyl cysteic acid, a sodium salt of the methyl ester of N-13-cis-retinoyl cysteic acid, or a combination thereof, in the preparation of a drug delivery system
Patent NZ-586925-A (NZ)
Title: A contoured panel with increasing density across its width, convex features having a high density surface
Inventor: LYNCH STEVEN
IPC: B29L31/10
Filed: 2010-07-21
Abstract: A panel and method of making a panel is disclosed. One described panel (150) comprises a core (156) comprising a flat region and a contoured region, wherein the contoured region comprises a convex feature (162), a first adjacent base (168) and a second adjacent base (172), the apex (164) of the convex feature (162) has a first caliper (166), the first adjacent base (168) has a second caliper (170) smaller than the first caliper (166), and the second adjacent base (172) has a third caliper (174) smaller than the first caliper (166). The panel and a method for making panels reduces the amount of material used per panel while also reducing fracturing and brown line defects on the surface of the mat.
Patent NZ-587981-A (NZ)
Title: Manipulation of organic acid biosynthesis and secretion with phosphoenolpyruvate carboxylase
Inventor: SPANGENBERG GERMAN
IPC: C12N15/29
Filed: 2004-04-14
Abstract: Disclosed is a substantially purified or isolated PEPC polypeptide from a Trifolium species, said polypeptide including an amino acid sequence selected from the group consisting of (a) sequences shown in Figures 87, 90, 93, 96, 98 and 111 hereto (SEQ ID NOS 311, 316, 320, 324, 326, and 348, respectively); and (b) functionally active fragments and variants having at least approximately 90% identity to the sequences recited in (a). Further disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment from a Trifolium species, said nucleic acid or nucleic acid fragment encoding phosphoenolpyruvate carboxylase ( PEPC), or complementary or antisense to a sequence encoding PEPC, said nucleic acid or nucleic acid fragment including a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 86, 88, 89, 91, 92, 94, 95, 97 and 110 hereto (SEQ ID NOS 310, 312 to 314, 315, 317 to 318, 319, 321 to 322, 323, 325 and 347 respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); (d) functionally active fragments and variants having at least approximately 95% identity to the sequences recited in (a), (b) and (c); and (e) RNA sequences corresponding to the sequences recited in (a), (b), (c) and (d).